In the largest group of results to date, researchers from Penn Medicine’s Abramson Cancer Center and other institutions have shown in clinical trials that the malaria drug hydroxychloroquine (HCQ) blocked autophagy in a host of aggressive cancers—glioblastoma, melanoma, lymphoma and myeloma, renal and colon cancers—and in some cases helped stabiliz
Perelman School of Medicine
The Penn Medicine Center for Health Care Innovation will fund three new initiatives in the second round of its Innovation Grant Program. The program encourages Penn employees and students to submit their ideas for advancing health and health care delivery.
Elizabeth Grice of the Perelman School of Medicine comments on a bacteria hygiene experiment.
Thomas Wadden of the Perelman School of Medicine comments on results from an obesity study.
David Seth Goldberg of the Perelman School of Medicine is quoted about the results from a study looking at the effect of geography on liver transplants and patient outcomes.
David Oslin of the Perelman School of Medicine comments on weaning elderly patients off medications they were prescribed to years ago.
David Weiner of the Perelman School of Medicine is quoted about helping develop treatment for Middle East Respiratory Syndrome.
Bridgette Brawner of the Perelman School of Medicine explains “geobehavioral vulnerability” and discusses HIV risk.
Nearly half of all adults in the United States suffer from the gum disease periodontitis, and 8.5 percent have a severe form that can raise the risk of heart disease, diabetes, arthritis and pregnancy complications.
Lee Goldberg of the Perelman School of Medicine is quoted about the effects of cardiac rehabilitation.